Varian's Trilogy offers hope for inoperable brain ailments

TriMed Staff | | Health Imaging | Diagnostic Imaging
Providence Hospital in Mobile, Ala., has begun treating patients once thought to have inoperable brain ailments with Varian Medical Systems' Trilogy stereotactic system. The advanced linear accelerator allows Providence physicians to perform non-invasive brain treatment without an incision, with minimal pain and oftentimes, with no hospitalization.
   
The Trilogy system combines image-guided radiotherapy (IGRT), stereotactic treatment and conformal radiotherapy (CRT) in one system. The system delivers a wide range of precise treatments making it easier to treat difficult conditions including cancer and certain neurological conditions.
   
Trilogy can be used to deliver all forms of external beam radiotherapy, including 3D conformal (3D-CRT), intensity-modulated radiotherapy (IMRT), image-guided radiotherapy (IGRT), and image-guided radiosurgery (IGRS).  Clinicians at Providence Hospital plan to use the Trilogy stereotactic system primarily to treat brain cancer and functional disorders such as trigeminal neuralgia.
   
Providence Hospital worked closely with Coastal Neurological Institute, PC (CNI) to be among the first in the nation to deploy the new technology along the Gulf Coast.

TriMed Staff

Related Content

AI rules out abnormal findings on chest X-rays, significantly reducing workloads
Older adults among the walking wounded with incident TBI
Philips moves digital pathology to the cloud with AWS
PHOTO GALLERY: What does fetal medical imaging look like?
Speaker laments radiology’s major contribution to climate change
Radiologist accuracy takes a hit overnight, especially with advanced imaging exams

Around the web

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

Cardiovascular Business
FDA clears AI tool that flags signs of heart disease in chest CT scans

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup